© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists
ORIGINAL ARTICLE
Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1
Federal Fluminense University, Medicine School, Pathology Department, Niterói, Rio de Janeiro, Brazil
Correspondence to:
Correspondence to:
Dr K S G Cunha, Rua do Catete, 311/Sala 1314, Catete, Rio de Janeiro, Brazil CEP 22220001;
karingoncalves{at}terra.com.br
Background: The hallmark of neurofibromatosis type 1 (NF1) is the development of multiple neurofibromas. Solitary neurofibroma may occur in an individual who does not have NF1, but multiple neurofibromas tend to develop only in those with NF1. It has been suggested that hormones may influence the neurofibromas of patients with NF1. The evidence that hormones may influence the growth of neurofibromas comes mainly from the observation that localised neurofibromas of patients with NF1 commonly grow during puberty and pregnancy. Because growth hormone (GH) concentrations increase during puberty, it is possible that GH influences the growth of these tumours.
Aims: To investigate the presence of GH receptors (GHRs) in neurofibromas.
Methods: By means of immunohistochemistry, the presence of GHRs was investigated in two groups of patients: 16 patients without NF1 with solitary neurofibromas (group A) and 10 patients with NF1 with localised neurofibromas (group B).
Results: Six of the 16 patients in group A had neurofibromas that were immunopositive for GHR, whereas nine of the 10 patients in group B were immunopositive.
Conclusions: Most patients with NF1 have localised neurofibromas that express GHR. This suggests that GH may play some role in the development of localised neurofibromas in patients with NF1.
Keywords: growth hormone; growth hormone receptor; neurofibroma; neurofibromatosis
Abbreviations: GAP, GTPase activation protein; GH, growth hormone; GHR, growth hormone receptor; IRS, insulin receptor substrate; MAP, mitogen activated protein; NF1, neurofibromatosis type 1; STAT, signal transducer and activator of transcription
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Reddy, G. R., Pushpanathan, M. J., Ransom, R. F., Holzman, L. B., Brosius, F. C. III, Diakonova, M., Mathieson, P., Saleem, M. A., List, E. O., Kopchick, J. J., Frank, S. J., Menon, R. K.
(2007). Identification of the Glomerular Podocyte as a Target for Growth Hormone Action. Endocrinology
148: 2045-2055
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
